 |
|
 |
 |

Home > Company Index > Drugs > Biotechnology-Medicine > Cell Genesys, Inc.
 |
Cell Genesys, Inc. |
 |
 |
 |
NEWS FROM THE WIRES |
 |
Cell Genesys promotes Joseph Vallner to president Aug 22 2001 04:24 AM PDT
Eurostocks drift early, BT, airlines in =2 Aug 06 2001 12:45 AM PDT
GPC/Cell Genesys achieve positive gene therapy test Aug 06 2001 12:44 AM PDT
Cell Genesys says to acquire Calydon Aug 02 2001 04:45 AM PDT
> More WIRE STORIES about this company
PROFILE |
 |
From Cell Genesys spring forth new gene therapies. The development-stage firm focuses on gene-modification technologies to treat such diseases as viral infections and cancer. With Japan Tobacco, the company is developing its GVAX treatment vaccines for lung, prostate, and pancreatic cancer, as well as for multiple myeloma, a blood cancer. Other projects include gene therapy research of treatments for hemophilia and cardiovascular disorders. Subsidiary Ceregene develops gene therapies for Parkinson's disease and other central nervous system disorders. Partners include EntreMed, Pharmacia, University of Michigan, and Abgenix, of which Cell Genesys owns about 10%.
COMPETITION |
 |
AVI BioPharma Inc. (AVII)
TRANSGENE S.A. (TRGNY)
Targeted Genetics Corporation (TGEN)
DEALS |
 |
Deal: T-Netix Acquires Cell-Tel
Date Announced: 01.05.99
Value of transaction (US $Mil): 45.5
Description: Call-processing and anti-fraud software company buys Web-based prisoner monitoring technology firm.
|
 |
STOCK ANALYSIS |
 |
FURTHER ANALYSIS
Advanced Charting
Deals
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: December
2000 Sales (mil.): 24.20
1-Yr. Sales Growth: (28.0)%
Employees: 162
Revenue per employee: $149,382.72
KEY PEOPLE |
 |
Stephen A. Sherwin
CEO
Matthew J. Pfeffer
CFO
CONTACT INFO |
 |
342 Lakeside Dr.
Foster City, CA 94404
US
Phone: 650-425-4400
Fax: 650-425-4457
Online: Web Site
|
 |
 |
 |
|
Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.
|

|
 |
 |
|
 |